Ampio Pharmaceuticals, Inc. (AMPE) financial statements (2021 and earlier)

Company profile

Business Address 373 INVERNESS PARKWAY
ENGLEWOOD, CO 80112
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1778852750
Cash and cash equivalents1778852750
Short-term investments   00  
Prepaid expense01   21
Derivative instruments and hedges, assets   00  
Other current assets     2 
Other undisclosed current assets11000(2)0
Total current assets:1888852951
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment45678910
Intangible assets, net (including goodwill)     38
Goodwill     0 
Intangible assets, net (excluding goodwill)     38
Regulated entity, other noncurrent assets     0 
Deposits noncurrent assets  00000
Other undisclosed noncurrent assets    081
Total noncurrent assets:466782119
TOTAL ASSETS:23141415145070
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2413133
Accounts payable00   33
Accrued liabilities00     
Employee-related liabilities 0     
Other undisclosed accounts payable and accrued liabilities13131  
Debt00     
Deferred rent credit  0
Due to related parties     1 
Deferred revenue and credits0000
Other undisclosed current liabilities   1110
Total current liabilities:2414264
Noncurrent Liabilities
Long-term debt and lease obligation11   5 
Long-term debt, excluding current maturities     5 
Operating lease, liability11
Liabilities, other than long-term debt32746521
Deferred revenue and credits1111
Deferred rent credit  0
Business combination, contingent consideration, liability     1 
Derivative instruments and hedges, liabilities3274540 
Other undisclosed noncurrent liabilities     0 
Total noncurrent liabilities:43746571
Total liabilities:589497125
Stockholders' equity
Stockholders' equity attributable to parent, including:18653473766
Common stock0000000
Additional paid in capital218191176171160171168
Accumulated deficit(201)(185)(171)(205)(153)(134)(102)
Other undisclosed stockholders' equity attributable to parent   68(0)(0)(0)
Stockholders' equity attributable to noncontrolling interest     1(1)
Other undisclosed stockholders' equity   (68)   
Total stockholders' equity:1865(34)73865
TOTAL LIABILITIES AND EQUITY:23141415145070

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues     10
Revenue, net  10
Cost of revenue
(Cost of Goods and Services Sold)
     (0) 
Gross profit:     10
Operating expenses(16)(19)(11)(16)(17)(34)(39)
Other operating income, net  45    
Other undisclosed operating income     0 
Operating income (loss):(16)(19)34(16)(17)(33)(39)
Nonoperating income (expense)(0)5 (36)(2)(0)0
Investment income, nonoperating(1)5 (36)(1)(0)0
Interest and debt expense     (0) 
Income (loss) from continuing operations before income taxes:(16)(14)34(52)(19)(34)(39)
Income tax benefit      5
Income (loss) before gain (loss) on sale of properties:(16)(14)34(52)(19)(34)(34)
Other undisclosed net income (loss)     0(5)
Net income (loss):(16)(14)34(52)(19)(34)(39)
Net income attributable to noncontrolling interest     21
Net income (loss) attributable to parent:(16)(14)34(52)(19)(32)(38)
Preferred stock dividends and other adjustments (5)     
Net income (loss) available to common stockholders, diluted:(16)(18)34(52)(19)(32)(38)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(16)(14)34(52)(19)(34)(39)
Comprehensive income (loss):(16)(14)34(52)(19)(34)(39)
Comprehensive income, net of tax, attributable to noncontrolling interest     21
Comprehensive income (loss), net of tax, attributable to parent:(16)(14)34(52)(19)(32)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: